- Latest available (Revised)
- Original (As made)
The Republic of Belarus (Sanctions) (EU Exit) Regulations 2019
You are here:
What Version
Advanced Features
- Show Geographical Extent(e.g. England, Wales, Scotland and Northern Ireland)
- Show Timeline of Changes
More Resources
Changes to legislation:
There are currently no known outstanding effects for the The Republic of Belarus (Sanctions) (EU Exit) Regulations 2019, PART 2.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
[F1PART 2U.K.
Textual Amendments
F1Sch. 2H inserted (9.6.2023) by The Republic of Belarus (Sanctions) (EU Exit) (Amendment) Regulations 2023 (S.I. 2023/616), reg. 1(2), Sch.
Chemical and biological weapons-related goods and chemical and biological weapons-related technology
| Chemical Name (1) | CAS Number (2) |
|---|---|
| Aluminium chloride | (7446-70-0) |
| Ammonia | (7664-41-7) |
| Dichloromethane | (75-09-2) |
| N,N-Dimethylaniline | (121-69-7) |
| Isopropyl bromide | (75-26-3) |
| Isopropyl ether | (108-20-3) |
| Monoisopropylamine | (75-31-0) |
| Potassium Bromide | (7758-02-3) |
| Pyridine | (110-86-1) |
| Sodium bromide | (7647-15-6) |
| Sodium metal | (7440-23-5) |
| Tributylamine | (102-82-9) |
| Triethylamine | (121-44-8) |
| Trimethylamine | (75-50-3) |
| Diethylenetriamine | (111-40-0) |
| Butyrylcholinesterase (BCHE) | Not Applicable |
| Pyridostigmine bromide | (101-26-8) |
| Obidoxime chloride | (114-90-9) |
| Acetylene | (CAS 74-86-2) |
| Acetone | (CAS 67-64-1) |
| Antimony | (CAS 7440-36-0) |
| Arsenic | (CAS 7440-38-2) |
| Arsenic trioxide | (CAS 1327-53-3) |
| Bis(2-chloroethyl)ethylamine hydrochloride | (CAS 3590-07-6) |
| Bis(2-chloroethyl)methylamine hydrochloride | (CAS 55-86-7) |
| Benzil | (CAS 134-81-6) |
| Benzaldehyde | (CAS 100-52-7) |
| Benzoin | (CAS 119-53-9) |
| 2-bromochloroethane | (CAS 107-04-0) |
| Chlorine | (CAS 7782-50-5) |
| Diethyl ether | (CAS 60-29-7) |
| Dimethyl ether | (CAS 115-10-6) |
| Dimethylaminoethanol | (CAS 108-01-0) |
| Dicyclohexylamine (DCA) | (CAS 101-83-7) |
| Ethylene | (CAS 74-85-1) |
| Ethylene dichloride | (CAS 107-06-2) |
| 2-methoxyethanol | (CAS 109-86-4) |
| Ethyl bromide | (CAS 74-96-4) |
| Ethyl chloride | (CAS 75-00-3) |
| Ethylamine | (CAS 75-04-7) |
| Ethylene oxide | (CAS 75-21-8) |
| Fluorapatite | (CAS 1306-05-4) |
| Hexamine | (CAS 100-97-0) |
| Hydrogen sulfide | (CAS 7783-06-4) |
| Isocyanatomethane | (CAS 624-83-9) |
| Isopropanol, 95% concentration or greater | (CAS 67-63-0) |
| Mandelic acid | (CAS 90-64-2) |
| Methylamine | (CAS 74-89-5) |
| Methyl bromide | (CAS 74-83-9) |
| Methyl chloride | (CAS 74-87-3) |
| Methyl iodide | (CAS 74-88-4) |
| Methylmercaptan | (CAS 74-93-1) |
| Monoethylene Glycol (MEG) | (CAS 107-21-1) |
| Nitromethane | (CAS 75-52-5) |
| Oxalyl chloride | (CAS 79-37-8) |
| Picric acid | (CAS 88-89-1) |
| Potassium sulfide | (CAS 1312-73-8) |
| Potassium thiocyanate | (CAS 333-20-0) |
| Quinaldine | (CAS 91-63-4) |
| Thiophosphoryl chloride | (CAS 3982-91-0) |
| Tributylphosphite | (CAS 102-85-2) |
| Triisobutylphosphite | (CAS 1606-96-8) |
| Tris(2-chloroethyl)amine hydrochloride | (CAS 817-09-4) |
| Sodium hypochlorite | (CAS 7681-52-9) |
| Sulfur trioxide | (CAS 7446-11-9) |
| White/yellow phosphorus | (CAS 12185-10-3, 7723-14-0) |
| Mercury | (7439-97-6) |
| Barium chloride | (10361v37-2) |
| Sulphuric acid, with a concentration by weight of 90% or greater | (7664-93-9) |
| 3,3-dimethyl-1-butene | (558-37-2) |
| 2,2-dimethylpropanal | (630-19-3) |
| 2,2-dimethylpropylchloride | (753-89-9) |
| 2-methylbutene | (26760-64-5) |
| 2-chloro-3-methylbutane | (631-65-2) |
| 2,3-dimethyl-2,3-butanediol | (76-09-5) |
| 2-methyl-2-butene | (513-35-9) |
| Butyl lithium | (109-72-8) |
| Bromo(methyl)magnesium | (75-16-1) |
| Formaldehyde | (50-00-0) |
| Diethanolamine | (111-42-2) |
| Dimethylcarbonate | (616-38-6) |
| Methyldiethanolamine hydrochloride | (54060-15-0) |
| Methanol | (67-56-1) |
| Ethanol | (64-17-5) |
| 1-butanol | (71-36-3) |
| 2-butanol | (78-92-2) |
| Iso-butanol | (78-83-1) |
| Tert-butanol | (75-65-0) |
| Cyclohexanol | (108-93-0) |
| Diethylamine hydrochloride | (660-68-4) |
| Diisopropylamine hydrochloride | (819-79-4) |
| 3-Quinuclidinone hydrochloride | (1193-65-3) |
| 3-Quinuclidinol hydrochloride | (6238-13-7) |
| (R)-3- Quinuclidinol hydrochloride | (42437-96-7) |
| N,N-Diethylaminoethanol hydrochloride | (14426-20-1) |
| Acetyl-alpha-methylfentanyl | 101860-00-8 |
| Alfentanil | 71195-58-9 |
| Alpha-methylfentanyl | 79704-88-4 |
| Alpha-methylthiofentanyl | 103963-66-2 |
| Beta-hydroxyfentanyl | 78995-10-5 |
| Beta-hydroxy-3-methylfentanyl | 78995-14-9 |
| Fentanyl | 437-38-7 |
| 3-methylfentanyl | 42045-86-3 |
| 3-methylthiofentanyl | 86052-04-2 |
| Para-fluorofentanyl | 90736-23-5 |
| Remifentanil | 132875-61-7 |
| Sufentanil | 56030-54-7 |
| Thiofentanyl | 60771-38-2 |
| Acryloylfentanyl (Acrylfentanyl) | 82003-75-6 |
| Carfentanil | 59708-52-0 |
| 4-Fluoroisobutyrfentanyl (4-FIBF, pFIBF) | 244195-32-2 |
| Furanyl fentanyl | 101345-66-8 |
| Ocfentanil | 101343-69-5 |
| Tetrahydrofuranyl fentanyl (THF-F) | 2142571-01-3 |
| Cyclopropylfentanyl | 1169-68-2 |
| Methoxyacetylfentanyl | 101345-67-9 |
| Orthofluorofentanyl | 910616-29-4 |
| Parafluorobutyrylfentanyl | 244195-31-1 |
| Crotonylfentanyl | 760930-59-4 |
| Valerylfentanyl | 122882-90-0 |
| 4-Anilino- N-phenethylpiperidine (ANPP) | 21409-26-7 |
| N-Phenethyl-4-piperidone (NPP) | 39742-60-4 |
| Dialkyl(≤C10) chlorophosphates | N/A |
| Dialkyl(≤C10) fluorophosphates | N/A |
| N,N-Methylisopropylacetamidine | 1339185-57-7 |
| N,N-Methylethylacetamidine | 1339632-40-4 |
| N,N-Ethylisopropylacetamidine | 1339156-10-3 |
| N,N-Methylpropylacetamidine | 1344238-28-3 |
| N,N-Ethylpropylacetamidine | 1339737-43-7 |
| N,N-Isopropylpropylacetamidine | 1341389-98-7 |
| N,N-Methylethylpropanamidine | 1339424-26-8 |
| N,N-Ethylisopropylpropanamidine | 1344354-09-1 |
| N,N-Methylpropylpropanamidine | 1340216-25-2 |
| N,N-Ethylpropylpropanamidine | 1341493-60-4 |
| N,N-Isopropylpropylpropanamidine | 1343225-93-3 |
| N,N-Methylisopropylpropanamidine | 1339042-55-5 |
| N,N-Methylethylbutanamidine | 1341049-51-1 |
| N,N-Methylpropylbutanamidine | 1343721-02-7 |
| N,N-Ethylpropylbutanamidine | 1343806-12-1 |
| N,N-Isopropylpropylbutanamidine | 1343316-02-8 |
| N,N-Methylisopropylbutanamidine | 1340219-94-4 |
| N,N-Ethylisopropylbutanamidine | 1342204-10-7 |
| N,N-Methylethylisobutanamidine | 1342365-47-2 |
| N,N-Ethylpropylisobutanamidine | 1342566-58-8 |
| N,N-Methylpropylisobutanamidine | 1342270-21-6 |
| N,N-Isopropylpropylisobutanamidine | 1342156-11-9 |
| N,N-Methylisopropylisobutanamidine | 1341992-96-8 |
| N,N-Ethylisopropylisobutanamidine | 1339048-76-8 |
| N,N-Dimethylacetamidine hydrobromide | 1801188-12-4 |
| N,N-Dimethylacetamidine hydrochloride | 2909-15-1 |
| N,N-Diethylacetamidine hydrochloride | 91400-32-7 |
| N,N-Diethylacetamidine hydrobromide | 78053-54-0 |
| N,N-Dimethylpropanamidine dihydrochloride | 79972-73-9 |
| N,N-Dimethylpropanamidine hydrochloride | 56776-15-9 |
| Calcium carbide | 75-20-7 |
| Carbon monoxide | 630-08-0 |
| Monoethyleneglycol | 107-21-1 |
| Sulphur | 7704-34-9 |
| Sulphur dioxide | 7446-09-5 |
Equipment
| Item (1) |
|---|
| Floor-mounted fume hoods (walk-in style) with a minimum nominal width of 2.5 metres. |
| Full face-mask air-purifying and air-supplying respirators. |
| Class II biosafety cabinets and glove boxes. |
| Batch centrifuges with a rotor capacity of 4 L or greater, usable with biological materials. |
| Fermenters with an internal volume of 10 L – 20 L, usable with biological materials. |
| Reaction vessels, reactors, agitators, heat exchangers, condensers, pumps (including single seal pumps), valves, storage tanks, containers, receivers, and distillation or absorption columns that meet AG performance parameters, regardless of their materials of construction. |
| Conventional or turbulent air-flow clean-air rooms and self-contained fan-HEPA filter units that may be used for P3 or P4 (BSL 3, BSL 4, L3, L4) containment facilities. |
| Vacuum pumps with a manufacturer’s specified maximum flow-rate greater than 1 m3/h (under standard temperature and pressure conditions), casings (pump bodies), preformed casing-liners, impellers, rotors, and jet pump nozzles designed for such pumps, in which all surfaces that come into direct contact with the chemicals being processed are made from controlled materials. |
| Laboratory equipment, including parts and accessories for such equipment, for the analysis or detection, destructive or non-destructive, of chemical substances. |
| Whole chlor-alkali electrolysis cells – mercury, diaphragm, and membrane. |
| Titanium electrodes (including those with coatings produced from other metal oxides), specially designed for use in chlor-alkali cells. |
| Nickel electrodes (including those with coatings produced from other metal oxides), specially designed for use in chlor-alkali cells. |
| Bipolar titanium nickel electrodes (including those with coatings produced from other metal oxides), specially designed for use in chlor-alkali cells. |
| Asbestos diaphragms specially designed for use in chlor-alkali cells. |
| Fluoropolymer based diaphragms specially designed for use in chlor-alkali cells. |
| Fluoropolymer based ion exchange membranes specially designed for use in chlor-alkali cells. |
| Compressors specially designed to compress wet or dry chlorine, regardless of material of construction. |
Microwave reactors— Machinery, plant or laboratory equipment, whether or not electrically heated, for the treatment of materials by a process involving a change of temperature such as heating 84 19 89 98 00. |
Microreactors— Instruments and apparatus for physical or chemical analysis: 90 27 89 90 00 BE (classified similar item to 90 27 80 17 90, now invalid due to code changes), for similar microreactors. |
Solid & Liquid Aerosol generating equipment— Mechanical appliances (whether or not hand-operated), for projecting, dispersing or spraying liquids or powders: 84 24 89 70 00. |
Laboratory equipment
| Item (1) |
|---|
| Next-generation (second generation) and third generation DNA and RNA sequencers |
| PCR Machines and qPCR (real-time) PCR machines |
| Solid phase DNA and RNA synthesisers |
| Peptide synthesizers |
| Automated nucleic acid extraction systems |
| Ultracentrifuges |
| Probe sonicators |
| Fast protein liquid chromatography (FPLC) systems (medium pressure chromatography systems) |
| Cell disruptors and tissue homogenisers, with a volume of 1 L or greater |
Associated Parts and Consumables
| Item (1) | (2) |
|---|---|
| Next generation (second generation) and third generation DNA and RNA sequencers | DNA and RNA sequencing reagent kits |
| Library and template preparation kits | |
| Cluster generation kits | |
| Flow cells | |
| PCR Machines and qPCR (real-time) PCR machines | |
| Solid phase DNA and RNA synthesisers | Nucleoside phosphoramidites |
| Columns | |
| Solid support resin | |
| Reagent kits | |
| Synthesis reagents | |
| Peptide synthesizers | Fmoc and T-Boc protected amino acids |
| Resins | |
| Synthesis reagents | |
| Automated nucleic acid extraction systems | Reagents |
| Rotor adapters | |
| Ultracentrifuges | Ultracentrifuge rotors with total capacity 1 L or greater |
| Probe sonicators | Sonicator probes over 25mm diameter |
| High volume (1 L or greater) sonicator continuous flow cell | |
| Fast protein liquid chromatography (FPLC) systems (medium pressure chromatography systems) | FPLC columns |
| Reagents | |
| Cell disruptors and tissue homogenisers |
Other related items
| Item (1) |
|---|
| 0B999 Specific processing equipment as follows: |
| a. Ring magnets. |
| b. Hot cells. |
| c. Glove boxes suitable for use with radioactive materials. |
| 0D999 Specific software, as follows: |
| a. Software for neutronic calculations/modelling; |
| b. Software for radiation transport calculations/modelling; |
| c. Software for hydrodynamic calculations/modelling. |
| 1A995 Protective and detection equipment as follows and specially designed components therefor. |
| a. Personal radiation monitoring dosimeters; |
b. Equipment limited by design or function to protect against hazards specific to civil industries, such as mining, quarrying, agriculture, pharmaceuticals, medical, veterinary, environmental, waste management, or to the food industry. Note: This entry does not control items for protection against chemical or biological agents that are consumer goods, packaged for retail sale or personal use, or medical products, such as latex exam gloves, latex surgical gloves, liquid disinfectant soap, disposable surgical drapes, surgical gowns, surgical foot covers, and surgical masks. |
| 1A999 Specific processing equipment as follows: |
| Radiation detection, monitoring and measurement equipment |
| Radiographic detection equipment such as x-ray converters, and storage phosphor image plates. |
| 1C991 Vaccines, immunotoxins, medical products, diagnostic and food testing kits, as follows. |
| Technical note:- For the purpose of this entry, ‘immunotoxins’ are monoclonal antibodies linked to a toxin with the intention of destroying a specific target cell while leaving adjacent cells intact. For the purpose of this entry, “medical products” are: (1) pharmaceutical formulations designed for testing and human (or veterinary) administration in the treatment of medical conditions, (2) prepackaged for distribution as clinical or medical products. For the purpose of this entry, “diagnostic and food testing kits” are specifically developed, packaged and marketed for diagnostic or public health purposes. For the purpose of this entry, “vaccine” is defined as a medicinal (or veterinary) product in a pharmaceutical formulation that is intended to stimulate a protective immunological response in humans or animals in order to prevent disease in those to whom or to which it is administered. |
| Technical Note: For purposes of the controls described in this entry ‘toxins’ refers to those toxins, or their subunits, controlled under 1C351.dof Annex I of the Dual-Use Regulation |
| a. Vaccines containing, or designed for use against, items controlled by 1C351, 1C353 or 1C354 of Annex I of the Dual-Use Regulation; |
| b. Immunotoxins containing items controlled by 1C351.d of Annex I of the Dual-Use Regulation; |
| c. Medical products that contain any of the following: |
| c.1. Toxins controlled by 1C351.d of Annex I of the Dual-Use Regulation (except for botulinum toxins controlled by [F21C351.d.1] of Annex I of the Dual-Use Regulation, conotoxins controlled by [F31C351.d.3] , of Annex I of the Dual-Use Regulation or items controlled for CW reasons under 1C351.d.11 or .d.12 of Annex I of the Dual-Use Regulation); or |
| c.2. Genetically modified organisms or genetic elements controlled by 1C353.a.3 of Annex I of the Dual-Use Regulation (except for those that contain, or code for, botulinum toxins controlled by [F41C351.d.1] of Annex I of the Dual-Use Regulation or conotoxins controlled by [F51C351.d.3] of Annex I of the Dual-Use Regulation); |
| d. Medical products not controlled by 1C991.c that contain any of the following: |
| d.1. Botulinum toxins controlled by [F61C351.d.1] of Annex I of the Dual-Use Regulation; |
| d.2. Conotoxins controlled by [F71C351.d.3] of Annex I of the Dual-Use Regulation; or |
| d.3. Genetically modified organisms or genetic elements controlled by 1C353.a.3 of Annex I of the Dual-Use Regulation that contain, or code for, botulinum toxins controlled by [F81C351.d.1] of Annex I of the Dual-Use Regulation or conotoxins controlled by [F91C351.d.3] of Annex I of the Dual-Use Regulation; |
| e. Diagnostic and food testing kits containing items controlled by 1C351.d of Annex I of the Dual-Use Regulation. |
Textual Amendments
F2Word in Sch. 2H Pt. 2 Table substituted (16.5.2024) by The Sanctions (EU Exit) (Miscellaneous Amendments and Revocations) Regulations 2024 (S.I. 2024/643), regs. 1(2), 4(23)(a)(i)
F3Word in Sch. 2H Pt. 2 Table substituted (16.5.2024) by The Sanctions (EU Exit) (Miscellaneous Amendments and Revocations) Regulations 2024 (S.I. 2024/643), regs. 1(2), 4(23)(a)(ii)
F4Word in Sch. 2H Pt. 2 Table substituted (16.5.2024) by The Sanctions (EU Exit) (Miscellaneous Amendments and Revocations) Regulations 2024 (S.I. 2024/643), regs. 1(2), 4(23)(b)(i)
F5Word in Sch. 2H Pt. 2 Table substituted (16.5.2024) by The Sanctions (EU Exit) (Miscellaneous Amendments and Revocations) Regulations 2024 (S.I. 2024/643), regs. 1(2), 4(23)(b)(ii)
F6Word in Sch. 2H Pt. 2 Table substituted (16.5.2024) by The Sanctions (EU Exit) (Miscellaneous Amendments and Revocations) Regulations 2024 (S.I. 2024/643), regs. 1(2), 4(23)(c)
F7Word in Sch. 2H Pt. 2 Table substituted (16.5.2024) by The Sanctions (EU Exit) (Miscellaneous Amendments and Revocations) Regulations 2024 (S.I. 2024/643), regs. 1(2), 4(23)(d)
F8Word in Sch. 2H Pt. 2 Table substituted (16.5.2024) by The Sanctions (EU Exit) (Miscellaneous Amendments and Revocations) Regulations 2024 (S.I. 2024/643), regs. 1(2), 4(23)(e)(i)
F9Word in Sch. 2H Pt. 2 Table substituted (16.5.2024) by The Sanctions (EU Exit) (Miscellaneous Amendments and Revocations) Regulations 2024 (S.I. 2024/643), regs. 1(2), 4(23)(e)(ii)
1C995 Mixtures that contain chemicals controlled by 1C350 or 1C450 of Annex 1 of the Dual-Use Regulation and medical, analytical, diagnostic, and food testing kits that contain chemicals controlled by 1C350, as follows:
For the purpose of this entry, “medical, analytical, diagnostic, and food testing kits” are pre-packaged materials of defined composition that are specifically developed, packaged and marketed for medical, analytical, diagnostic, or public health purposes.
a. Mixtures containing the following concentrations of precursor chemicals controlled by 1C350 of Annex I of the Dual-Use Regulation:
a.1. Mixtures containing 10 per cent or less, by weight, of any of the following—
| Chemical Name (1) | CAS Number (2) |
|---|---|
| Arsenic trichloride; | 7784-34-1 |
| Benzilic acid; | 76-93-7 |
| Diethyl ethylphosphonate; | 78-38-6 |
| Diethyl methylphosphonate; | 683-08-9 |
| Diethyl methylphosphonite | 15715-41-0 |
| Diethyl-N,N-dimethylphosphoroamidate; | 2404-03-7 |
| N,N-Diisopropylaminoethanethiol hydrochloride; | 41480-75-5 |
| N,N-Diisopropyl-beta-aminoethane thiol; | 5842-07-9 |
| N,N-Diisopropyl-beta-aminoethanol; | 96-80-0 |
| N,N-Diisopropyl-beta-aminoethyl chloride; | 96-79-7 |
| N,N-Diisopropyl-beta-aminoethyl chloride hydrochloride; | 4261-68-1 |
| Dimethyl ethylphosphonate; | 6163-75-3 |
| Dimethyl methylphosphonate; | 756-79-6 |
| N,N-dimethylamino-phosphoryl dichloride; | 677-43-0 |
| Ethyl phosphonous dichloride [Ethyl phosphinyl dichloride]; | 1498-40-4 |
| Ethyl phosphonus difluoride [Ethyl phosphinyl difluoride]; | 430-78-4 |
| Ethyl phosphonyl dichloride; | 1066-50-8 |
| Methylphosphonic acid; | 993-13-5 |
| Methylphosphonothioic dichloride. | 676-98-2 |
| Pinacolyl alcohol; | 464-07-3 |
| 3-Quinuclidinol; | 1619-34-7 |
| Thiodiglycol. | 111-48-8 |
a.2. Mixtures containing less than 30 per cent., by weight, of:
a.2.a. Any of the following—
| Chemical Name | CAS Number |
|---|---|
| Diethyl phosphite; | 762-04-9 |
| Dimethyl phosphite (dimethyl hydrogen phosphite); | 868-85-9 |
| Ethyldiethanolamine; | 139-87-7 |
| Phosphorus oxychloride; | 10025-87-3 |
| Phosphorus pentachloride; | 10026-13-8 |
| Phosphorus trichloride; | 7719-12-2 |
| Sulfur dichloride; | 10545-99-0 |
| Sulfur monochloride; | 10025-67-9 |
| Thionyl chloride; | 7719-09-7 |
| Triethanolamine; | 102-71-6 |
| Triethyl phosphite; | 122-52-1 |
| Trimethyl phosphite. | 121-45-9 |
or
a.2.b. Any of the following single precursor chemicals—
| Chemical Name (1) | CAS Number (2) |
|---|---|
| Ammonium hydrogen fluoride; | 1341-49-7 |
| 2-Chloroethanol; | 107-07-3 |
| Diethylamine; | 109-89-7 |
| N,N-Diethylaminoethanol; | 100-37-8 |
| Diethyl chlorophosphite; | 589-57-1 |
| O,O-Diethyl phosphorodithioate; | 298-06-6 |
| O,O-Diethyl phosphorothioate; | 2465-65-8 |
| Di-isopropylamine; | 108-18-9 |
| Dimethylamine; | 124-40-3 |
| Dimethylamine hydrochloride; | 506-59-2 |
| Ethyl chlorofluorophosphate; | 762-77-6 |
| Ethyl dichlorophosphate; | 1498-51-7 |
| Ethyl difluorophosphate; | 460-52-6 |
| Hydrogen fluoride; | 7664-39-3 |
| 3-Hydroxyl-1-methylpiperidine; | 3554-74-3 |
| Methyl benzilate; | 76-89-1 |
| Methyl chlorofluorophosphate; | 754-01-8 |
| Methyl dichlorophosphate; | 677-24-7 |
| Methyl difluorophosphate; | 22382-13-4 |
| N,N Diethylacetamidine; | 14277-06-6 |
| N,N-Diethylbutanamidine; | 53510-30-8 |
| N,N-Diethylformamidine; | 90324-67-7 |
| N,N Diethylisobutanamidine; | 1342789-47-2 |
| N,N-Diethylpropanamidine; | 84764-73-8 |
| N,N-Diisopropylbutanamidine; | 1315467-17-4 |
| N,N-Diisopropylformamidine; | 857522-08-8 |
| N,N-Dimethylacetamidine; | 2909-14-0 |
| N,N-Dimethylbutanamidine; | 1340437-35-5 |
| N,N-Dimethylformamidine; | 44205-42-7 |
| N,N-Dimethylisobutanamidine; | 321881-25-8 |
| N,N-Dimethylpropanamidine; | 56776-14-8 |
| N,N-Dipropylacetamidine; | 1339586-99-0 |
| N,N-Dipropylbutanamidine; | 1342422-35-8 |
| N,N-Dipropylformamidine; | 48044-20-8 |
| N,N-Dipropylisobutanamidine; | 1342700-45-1 |
| N,N-Dipropylpropanamidine; | 1341496-89-6 |
| Phosphorus pentasulfide; | 1314-80-3 |
| Pinacolone; | 75-97-8 |
| Potassium bifluoride; | 7789-29-9 |
| Potassium cyanide; | 151-50-8 |
| Potassium fluoride; | 7789-23-3 |
| 3-Quinuclidone; | 3731-38-2 |
| Sodium bifluoride; | 1333-83-1 |
| Sodium cyanide; | 143-33-9 |
| Sodium fluoride; | 7681-49-4 |
| Sodium hexafluorosilicate; | 16893-85-9 |
| Sodium sulfide; | 1313-82-2 |
| Triethanolamine hydrochloride; | 637-39-8 |
| Tri-isopropyl phosphite. | 116-17-6 |
b. Mixtures containing the following concentrations of toxic or precursor chemicals controlled by 1C450 of Annex I of the Dual-Use Regulation—
b.1. Mixtures containing the following concentrations of CWC Schedule 2 chemicals controlled by 1C450.a.2, 1C450.b1, 1C450.b2, 1C450.b.3, 1C450.b.4, 1C450.b.5 or 1C450.b.6 of Annex I of the Dual-Use Regulation;
b.1.a. Mixtures containing 1 per cent. or less, by weight, of any single CWC Schedule 2 chemical controlled by 1C450.a.2 of Annex I of the Dual-Use Regulation (i.e., mixtures containing PFIB); or
b.1.b. Mixtures containing 10 per cent. or less, by weight, of any single CWC Schedule 2 chemical controlled by 1C450.b1, 1C450.b2, 1C450.b.3, 1C450.b.4, 1C450.b.5 or 1C450.b.6 of Annex I of the Dual-Use Regulation.
b.2. Mixtures containing less than 30 per cent., by weight, of any single CWC Schedule 3 chemical controlled by 1C450.a.4, 1C450.a.5, 1C450.a.6, 1C450.a.7, 1C450.b.8, of Annex I of the Dual-Use Regulation.
c. “Medical, analytical, diagnostic, and food testing kits” that contain precursor chemicals controlled by the following in an amount not exceeding 300 grams per chemical.
| Chemical Name (1) | CAS Number (2) |
|---|---|
| Ammonium hydrogen fluoride; | 1341-49-7 |
| 2-Chloroethanol; | 107-07-3 |
| Diethylamine; | 109-89-7 |
| N,N-Diethylaminoethanol; | 100-37-8 |
| Diethyl chlorophosphite; | 589-57-1 |
| O,O-Diethyl phosphorodithioate; | 298-06-6 |
| O,O-Diethyl phosphorothioate; | 2465-65-8 |
| Di-isopropylamine; | 108-18-9 |
| Dimethylamine; | 124-40-3 |
| Dimethylamine hydrochloride; | 506-59-2 |
| Ethyl chlorofluorophosphate; | 762-77-6 |
| Ethyl dichlorophosphate; | 1498-51-7 |
| Ethyl difluorophosphate; | 460-52-6 |
| Hydrogen fluoride; | 7664-39-3 |
| 3-Hydroxyl-1-methylpiperidine; | 3554-74-3 |
| Methyl benzilate; | 76-89-1 |
| Methyl chlorofluorophosphate; | 754-01-8 |
| Methyl dichlorophosphate; | 677-24-7 |
| Methyl difluorophosphate; | 22382-13-4 |
| N,N Diethylacetamidine; | 14277-06-6 |
| N,N-Diethylbutanamidine; | 53510-30-8 |
| N,N-Diethylformamidine; | 90324-67-7 |
| N,N Diethylisobutanamidine; | 1342789-47-2 |
| N,N-Diethylpropanamidine; | 84764-73-8 |
| N,N-Diisopropylbutanamidine; | 1315467-17-4 |
| N,N-Diisopropylformamidine; | 857522-08-8 |
| N,N-Dimethylacetamidine; | 2909-14-0 |
| N,N-Dimethylbutanamidine; | 1340437-35-5 |
| N,N-Dimethylformamidine; | 44205-42-7 |
| N,N-Dimethylisobutanamidine; | 321881-25-8 |
| N,N-Dimethylpropanamidine; | 56776-14-8 |
| N,N-Dipropylacetamidine; | 1339586-99-0 |
| N,N-Dipropylbutanamidine; | 1342422-35-8 |
| N,N-Dipropylformamidine; | 48044-20-8 |
| N,N-Dipropylisobutanamidine; | 1342700-45-1 |
| N,N-Dipropylpropanamidine; | 1341496-89-6 |
| Phosphorus pentasulfide; | 1314-80-3 |
| Pinacolone; | 75-97-8 |
| Potassium bifluoride; | 7789-29-9 |
| Potassium cyanide; | 151-50-8 |
| Potassium fluoride; | 7789-23-3 |
| 3-Quinuclidone; | 3731-38-2 |
| Sodium bifluoride; | 1333-83-1 |
| Sodium cyanide; | 143-33-9 |
| Sodium fluoride; | 7681-49-4 |
| Sodium hexafluorosilicate; | 16893-85-9 |
| Sodium sulfide; | 1313-82-2 |
| Triethanolamine hydrochloride; | 637-39-8 |
| Tri-isopropyl phosphite. | 116-17-6] |
Options/Help
Print Options
PrintThe Whole Instrument
PrintThe Whole Schedule
PrintThis Part only
You have chosen to open The Whole Instrument
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
You have chosen to open The Whole Instrument as a PDF
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
You have chosen to open the Whole Instrument
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
See additional information alongside the content
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Opening Options
Different options to open legislation in order to view more content on screen at once
Explanatory Memorandum
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as enacted version that was used for the print copy
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
Timeline of Changes
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as made version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.